Phase II trial of chronomodulated infusion of 5-fluorouracil and folinic acid in metastatic colorectal cancer

Anticancer Research

Volumn 20, Issue 6 C, 2000, Pages 4649-4653

  Cure, H ^a   Chevalier, V ^a   Pezet, D ^a   Bousquet, J ^a   Focan, C ^a   Levi, F ^a   Garufi, C ^a   Chipponi, J ^a   Chollet, P ^a  

^a CENTRE JEAN PERRIN   (France)

Author keywords

5 fluorouracil; Chronotherapy; Folinic acid; Metastatic colorectal cancer

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CHRONOPHARMACOLOGY; CHRONOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; META ANALYSIS; METASTASIS; MUCOSA INFLAMMATION; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CIRCADIAN RHYTHM; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; TREATMENT OUTCOME;

EID: 0034494146     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Advanced colorectal cancer meta-analysis project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate
2. Treatment of advanced colorectal and gastric adenocarcinoma with 5-FU combined with high-dose folinic acid: A pilot study
3. A randomised trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma
4. Biochemical modulation of fluorouracil: Evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma
5. Comparison of 5-fluorouracil with 5-fluorouracil, cyclophosphamide, and methotrexate in metastatic colorectal carcinoma
6. Interindividual differences in the circadian hematologic time structure of cancer patients
7. Decreased nocturnal melatonin peak in patients with estrogen receptor positive breast cancer
8. Circadian time structure of serum biochemical variables in patients with metastatic breast cancer
9. DNA synthetis in human bone marrow is circadian stage dependent
10. Chronotherapy of advanced breast cancer with continuous doxorubicin infusion via an implantable programmable device
11. Circadian patterning of continuous floxuridine infusion reduces toxicity and allows higher dose intensity in patients with widespread cancer
12. Phase I trial of 5-day continuous venous infusion of oxaliplatinium at circadian-modulated vs constant rate
13. Comparative murine chronotoxicity of anticancer agents and related mechanisms
14. Circadian timing of cancer chemotherapy
15. Diurnal variation in the therapeutic efficacy of 5-fluorouracil against murine colon cancer
16. A phase I-II trial of five-day continous intravenous infusion of 5-fluorouracil delivered at circadian rhythm modulated rate in patients with metastatic colorectal cancer
17. Ambulatory 5-day chronotherapy of colorectal cancer with continous infusion of 5-fluorouracil (CVI-5-FU) at circadian modulated rate
18. Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continous venous infusion at circadian rhythm modulated rate
19. A chronopharmacology phase II clinical trial with 5-fluorouracil, folinic acid and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer
20. Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: A randomised multi-institutional trial
21. Improved therapeutic index through ambulatory circadian rhythmic delivery (CRD) of high dose 3-drug chemotherapy in a randomized phase II multicenter trial
22. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high dose folinic acid
23. A multicenter evaluation of intensified, ambulatory, chronomodualted chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as initial treatment of patients with metastatic colorectal carcinoma
24. Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil and folinic acid in patients with metastatic colorectal cancer
25. Phase III multicenter randomized trial of oxaliplatin addition to chronomodualated 5-fluorouracil-Leucovorin as first line treatment of metastatic colorectal cancer
26. Phase I study of 5-fluorouracil and leucovorin by a 14-day circadian infusion in patients with metastatic adenocarcinoma
27. Chronotherapy with 5-fluorouracil and folinic acid in advanced colorectal cancer. Results of a chrono-pharmacologic phase I trial
28. Chronoinfusion with 5-fluorouracil and 1-folinic acid: A randomized phase I study
29. A phase I trial of five day chronomodulated infusion of 5-fluorouracil (5-FU) and L-folinic acid in patients with metastatic colorectal cancer